Non small cell lung cancer radiation therapy: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) m Gerald Chi- moved page Non small cell carcinoma of the lung radiation therapy to Non small cell lung cancer radiation therapy without leaving a redirect |
No edit summary |
||
| (15 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Non small cell lung cancer}} | {{Non small cell lung cancer}} | ||
{{CMG}}; {{AE}} {{Alonso}} | {{CMG}}; {{AE}} {{Alonso}} {{MV}} | ||
==Overview== | ==Overview== | ||
[[Radiation therapy]] can be applied to any stage of non-small cell lung cancer. In general, radiation therapy is recommended as palliative care treatment among patients who develop an advanced stage of non-small cell lung cancer or symptomatic patients with local involvement (pain, [[vocal cord paralysis]], and [[hemoptysis]]). Curative radiation therapy may be indicated in patients who are not suitable for surgery with early-stage non-small cell lung cancer. The main goal of radiation therapy for non-small cell lung cancer is maximum [[tumor]] control with minimal [[tissue]] toxicity. The two main types of radiation therapy for non-small cell lung cancer are [[external beam radiation therapy]] (thoracic radiotherapy), and [[brachytherapy]] (internal radiation therapy). | |||
== | ==Radiation Therapy == | ||
=== | === Radiation Therapy Regimens === | ||
Shown below is a list of the different regimens radiation therapy for patients with non-small cell lung cancer. The list of regimens has been adapted from the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="radio">Pattern of use of radiotherapy for lung cancer: a descriptive study. BioMed Central. http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-697#CR6 Accessed on March 1, 2016</ref><ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | |||
=== | ====Usual Dosages for Definitive Radiation Therapy==== | ||
Administer fractions of 2 Gy over a period of 6 to 7.5 weeks to a total dose of 60 to 74 Gy | |||
===Stereotactic Ablative Radiotherapy Usual Dosage=== | ====Neoadjuvant Radiation Therapy Regimen==== | ||
Administer fractions of 1.8 to 2 Gy over a period of 5 weeks to a total dose of 45 to 50 Gy | |||
====Adjuvant Radiation Therapy Regimens==== | |||
* Negative surgical piece margins: Administer fractions of 1.8 to 2 Gy over a period of 5 to 6 weeks to a total dose of 40 to 54 Gy | |||
* Positive surgical piece margins: Administer fractions of 1.8 to 2 Gy over a period of 6 weeks to a total dose of 54 to 60 Gy | |||
* Extracapsular nodal extension: Administer fractions of 1.8 to 2 Gy over a period of 6 weeks to a total dose of 60 to 70 Gy | |||
* Residual tumor: Administer fractions of 2 Gy over a period of 6 to 7 weeks to a total dose of 54 to 60 Gy | |||
====Stereotactic Ablative Radiotherapy Usual Dosage==== | |||
* Peripheral small tumors: 25 to 34 Gy not fractioned. | * Peripheral small tumors: 25 to 34 Gy not fractioned. | ||
* Peripheral tumors and chest wall tumors larger than 1 cm: 45 to 60 Gy administered in 3 fractions | * Peripheral tumors and chest wall tumors larger than 1 cm: 45 to 60 Gy administered in 3 fractions | ||
* Central or peripheral tumors smaller than 5 cm: 48 to 60 Gy administered in 4 fractions | * Central or peripheral tumors smaller than 5 cm: 48 to 60 Gy administered in 4 fractions | ||
* Central or peripheral tumors principally chest wall tumors smaller that 1 cm: 50 to 55 Gy administered in 5 fractions | * Central or peripheral tumors principally chest wall tumors smaller that 1 cm: 50 to 55 Gy administered in 5 fractions | ||
* Central tumors: 60 to 70 Gy administered in 8 to 10 fractions | * Central tumors: 60 to 70 Gy administered in 8 to 10 fractions | ||
==Palliative Radiation Therapy Regimens== | ==Palliative Radiation Therapy Regimens== | ||
Listed bellow are the recommended palliative radiation therapy regimens for patients with non-small cell lung cancer according to the 2014 NCCN Non-Small Cell Lung Cancer guidelines<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | Listed bellow are the recommended palliative radiation therapy regimens for patients with non-small cell lung cancer according to the 2014 NCCN Non-Small Cell Lung Cancer guidelines.<ref name="NCCN">http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf</ref> | ||
* Obstructive disease: Administer fractions of 3 Gy over a period of 2 to 3 weeks to a total dose of 30 to 45 Gy | * Obstructive disease | ||
* Bone metastases associated with soft tissue mass: Administer fractions of 4 to 3 Gy over a period of 1 to 2 weeks to a total dose of 20 to 30 Gy | :* Administer fractions of 3 Gy over a period of 2 to 3 weeks to a total dose of 30 to 45 Gy | ||
* Bone metastases not associated with soft tissue mass: Administer fractions of 8 to 3 Gy over a period of 1 to 14 days to a total dose of 8 to 30 Gy | * [[Bone metastases]] associated with soft tissue mass | ||
* Patients with poor performance status and symptomatic chest disease: Administer fractions of 8.5 Gy over a period of 7 to 14 days to a total dose of 17 Gy | :*Administer fractions of 4 to 3 Gy over a period of 1 to 2 weeks to a total dose of 20 to 30 Gy | ||
* Metastatic disease in patients who have a poor performance status: Administer fractions of 8 to 4 Gy over a period of 1 to 7 days to a total dose of 8 to 20 Gy | * Bone metastases not associated with soft tissue mass | ||
* Whole brain radiation therapy regimens for metastases to the brain | :* Administer fractions of 8 to 3 Gy over a period of 1 to 14 days to a total dose of 8 to 30 Gy | ||
:* 10 fractions of 3 Gy each to a total of 30 Gy | * Patients with poor performance status and symptomatic chest disease | ||
:* 15 fractions of 2.5 Gy each to a total of 37.5 Gy | :*Administer fractions of 8.5 Gy over a period of 7 to 14 days to a total dose of 17 Gy | ||
:* 5 fractions of 4 Gy each to a total of 20 Gy. Good option for patients with poor performance status | * Metastatic disease in patients who have a poor performance status: | ||
:*Administer fractions of 8 to 4 Gy over a period of 1 to 7 days to a total dose of 8 to 20 Gy | |||
* Whole brain radiation therapy regimens for metastases to the brain, include the following: | |||
:* 10 fractions of 3 Gy each to a total of 30 Gy | |||
:* 15 fractions of 2.5 Gy each to a total of 37.5 Gy | |||
:* 5 fractions of 4 Gy each to a total of 20 Gy. Good option for patients with poor performance status | |||
==References== | ==References== | ||
| Line 51: | Line 59: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Pulmonology]] | |||
[[Category:Surgery]] | |||
Latest revision as of 23:37, 23 February 2018
|
Non Small Cell Lung Cancer Microchapters |
|
Differentiating Non Small Cell Lung Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non small cell lung cancer radiation therapy On the Web |
|
American Roentgen Ray Society Images of Non small cell lung cancer radiation therapy |
|
Directions to Hospitals Treating Non small cell carcinoma of the lung |
|
Risk calculators and risk factors for Non small cell lung cancer radiation therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Alonso Alvarado, M.D. [2] Maria Fernanda Villarreal, M.D. [3]
Overview
Radiation therapy can be applied to any stage of non-small cell lung cancer. In general, radiation therapy is recommended as palliative care treatment among patients who develop an advanced stage of non-small cell lung cancer or symptomatic patients with local involvement (pain, vocal cord paralysis, and hemoptysis). Curative radiation therapy may be indicated in patients who are not suitable for surgery with early-stage non-small cell lung cancer. The main goal of radiation therapy for non-small cell lung cancer is maximum tumor control with minimal tissue toxicity. The two main types of radiation therapy for non-small cell lung cancer are external beam radiation therapy (thoracic radiotherapy), and brachytherapy (internal radiation therapy).
Radiation Therapy
Radiation Therapy Regimens
Shown below is a list of the different regimens radiation therapy for patients with non-small cell lung cancer. The list of regimens has been adapted from the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[1][2]
Usual Dosages for Definitive Radiation Therapy
Administer fractions of 2 Gy over a period of 6 to 7.5 weeks to a total dose of 60 to 74 Gy
Neoadjuvant Radiation Therapy Regimen
Administer fractions of 1.8 to 2 Gy over a period of 5 weeks to a total dose of 45 to 50 Gy
Adjuvant Radiation Therapy Regimens
- Negative surgical piece margins: Administer fractions of 1.8 to 2 Gy over a period of 5 to 6 weeks to a total dose of 40 to 54 Gy
- Positive surgical piece margins: Administer fractions of 1.8 to 2 Gy over a period of 6 weeks to a total dose of 54 to 60 Gy
- Extracapsular nodal extension: Administer fractions of 1.8 to 2 Gy over a period of 6 weeks to a total dose of 60 to 70 Gy
- Residual tumor: Administer fractions of 2 Gy over a period of 6 to 7 weeks to a total dose of 54 to 60 Gy
Stereotactic Ablative Radiotherapy Usual Dosage
- Peripheral small tumors: 25 to 34 Gy not fractioned.
- Peripheral tumors and chest wall tumors larger than 1 cm: 45 to 60 Gy administered in 3 fractions
- Central or peripheral tumors smaller than 5 cm: 48 to 60 Gy administered in 4 fractions
- Central or peripheral tumors principally chest wall tumors smaller that 1 cm: 50 to 55 Gy administered in 5 fractions
- Central tumors: 60 to 70 Gy administered in 8 to 10 fractions
Palliative Radiation Therapy Regimens
Listed bellow are the recommended palliative radiation therapy regimens for patients with non-small cell lung cancer according to the 2014 NCCN Non-Small Cell Lung Cancer guidelines.[2]
- Obstructive disease
- Administer fractions of 3 Gy over a period of 2 to 3 weeks to a total dose of 30 to 45 Gy
- Bone metastases associated with soft tissue mass
- Administer fractions of 4 to 3 Gy over a period of 1 to 2 weeks to a total dose of 20 to 30 Gy
- Bone metastases not associated with soft tissue mass
- Administer fractions of 8 to 3 Gy over a period of 1 to 14 days to a total dose of 8 to 30 Gy
- Patients with poor performance status and symptomatic chest disease
- Administer fractions of 8.5 Gy over a period of 7 to 14 days to a total dose of 17 Gy
- Metastatic disease in patients who have a poor performance status:
- Administer fractions of 8 to 4 Gy over a period of 1 to 7 days to a total dose of 8 to 20 Gy
- Whole brain radiation therapy regimens for metastases to the brain, include the following:
- 10 fractions of 3 Gy each to a total of 30 Gy
- 15 fractions of 2.5 Gy each to a total of 37.5 Gy
- 5 fractions of 4 Gy each to a total of 20 Gy. Good option for patients with poor performance status
References
- ↑ Pattern of use of radiotherapy for lung cancer: a descriptive study. BioMed Central. http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-697#CR6 Accessed on March 1, 2016
- ↑ 2.0 2.1 http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf